Accessibility: Skip TopNav
Genentech, Inc. (F. Hoffmann-La Roche Ltd), to be the leading player in the lung cancer therapeutics market
Targeted Therapy to account for the highest market share by 2026
Format
PNG
Source
Fortune Business Insights
Downloads
Original
Large
Medium
Small